Literature DB >> 19488910

Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.

Esra Gunduz1, Mehmet Gunduz, Mahmoud Al Sheik Ali, Levent Beder, Ryo Tamamura, Naoki Katase, Susumu Tominaga, Noboru Yamanaka, Kenji Shimizu, Hitoshi Nagatsuka.   

Abstract

We have analyzed allelic loss of the short arm of chromosome 9 in 39 head and neck cancers using 13 polymorphic markers and found two deletions of hot spots at 9p21 and 9p24. Loss of heterozygosity was detected at least at one locus in 28 of 39 cases (71.8%). P16, a well-known tumor suppressor gene, is considered to be a target for deletion of the 9p21 region. However, novel frequent chromosomal deletion and a candidate tumor suppressor gene, BRM at the 9p24 region, were detected. Moreover, comparison of clinicopathological variables demonstrated that loss of heterozygosity at the BRM locus was associated with a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488910     DOI: 10.1080/07357900802563010

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  12 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 3.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

4.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

5.  Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.

Authors:  Krystal A Orlando; Vinh Nguyen; Jesse R Raab; Tara Walhart; Bernard E Weissman
Journal:  Expert Rev Anticancer Ther       Date:  2019-05-13       Impact factor: 4.512

6.  Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.

Authors:  G Liu; S Gramling; D Munoz; D Cheng; A K Azad; M Mirshams; Z Chen; W Xu; H Roberts; F A Shepherd; M S Tsao; D Reisman
Journal:  Oncogene       Date:  2011-04-11       Impact factor: 9.867

7.  SAQC: SNP array quality control.

Authors:  Hsin-Chou Yang; Hsin-Chi Lin; Meijyh Kang; Chun-Houh Chen; Chien-Wei Lin; Ling-Hui Li; Jer-Yuarn Wu; Yuan-Tsong Chen; Wen-Harn Pan
Journal:  BMC Bioinformatics       Date:  2011-04-18       Impact factor: 3.169

8.  Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variants.

Authors:  Min Yang; Yuan Sun; Ling Ma; Chenguang Wang; Jian-Min Wu; Anding Bi; D Joshua Liao
Journal:  J Cancer       Date:  2011-07-06       Impact factor: 4.207

9.  Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment.

Authors:  Oluwole Fadare; Idris L Renshaw; Sharon X Liang
Journal:  J Cancer       Date:  2012-03-10       Impact factor: 4.207

10.  A genome-wide homozygosity association study identifies runs of homozygosity associated with rheumatoid arthritis in the human major histocompatibility complex.

Authors:  Hsin-Chou Yang; Lun-Ching Chang; Yu-Jen Liang; Chien-Hsing Lin; Pei-Li Wang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.